Assembly of the TLR2/6 transmembrane domains is essential for activation and is a target for prevention of sepsis

Avner Fink, Eliran M. Reuven, Christopher J. Arnusch, Liraz Shmuel-Galia, Niv Antonovsky, Yechiel Shai

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

TLR2, together with TLR1 and TLR6, is essential for detecting lipopeptides and bacterial cell wall components such as lipoteichoic acid from Gram-positive bacteria. In this study, we report that transmembrane domain (TMD)-derived peptides from TLR2 and TLR6 specifically inhibit TLR2 activation. Secretion of the cytokines TNF-α and IL-6 by cultured macrophages (RAW264.7 cell line) was inhibited by these peptides in response to TLR2 activation by lipoteichoic acid (TLR2/6 activator) or palmitoyl (3)-Cys-Ser-Lys(4)-OH (TLR2/1 activator) but not by LPS (TLR4 activator). Extensive biophysical and biochemical assays, combined with GALLEX experiments, show that these peptides heterodimerize with their complementary TMDs on their reciprocal protein. These results suggest that TLR2/6/1 TMD assembly is essential for activating this complex. Importantly, when administered to mice inflicted by TLR2, but not TLR4-driven lethal inflammation, a selected peptide rescued 60% of these septic mice, showing potent in vivo inhibition of TNF-α and IL-6 secretion. Furthermore, this peptide also showed high protection in a whole bacteria model. Owing to the importance of TLR2 regulation under a variety of pathological conditions, compounds that can fine-tune this activity are of great importance.

Original languageEnglish
Pages (from-to)6410-6422
Number of pages13
JournalJournal of Immunology
Volume190
Issue number12
DOIs
StatePublished - 15 Jun 2013

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Assembly of the TLR2/6 transmembrane domains is essential for activation and is a target for prevention of sepsis'. Together they form a unique fingerprint.

Cite this